MELANIE PRIEBE: Open Payments
NPI 1255417861 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 47 payments from 13 companies in 2025. Trend: 2023 $1,354 · 2024 $1,242 · 2025 $825
Food & beverage: $714Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $205 |
| E.R. Squibb & Sons, L.L.C. | 12 | $188 |
| ABBVIE INC. | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Alkermes, Inc. | 2 | $40 |
| Almatica Pharma LLC | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
Products named: COBENFY, VRAYLAR, AUSTEDO XR, FANAPT, CAPLYTA, TRINTELLIX, ARISTADA, LOREEV XR.
Industry payments across PA — which companies pay providers there.
